ORBIMED ADVISORS LLC 13D/13G Filings for

ORBIMED ADVISORS LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-08-19
5:14 pm
Sale		 2020-08-06 13G ESSA Pharma Inc.
EPIX		 ORBIMED ADVISORS LLC 1,177,483
4.100%		 -294,370decrease
(-20.00%)		 Filing